March 12, 2020 / 10:04 PM / 16 days ago

BRIEF-ADMA Biologics Reports Q4 Loss Per Share Of $0.18

March 12 (Reuters) - ADMA Biologics Inc:

* ADMA BIOLOGICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS

* Q4 LOSS PER SHARE $0.18

* Q4 REVENUE $12 MILLION VERSUS REFINITIV IBES ESTIMATE OF $10.4 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $-0.17 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below